Who has invested in HilleVax?

Frazier Life Sciences are named among the investors backing HilleVax.

HilleVax Funding: $135M Raised, IPO (2021)

HilleVax funding overview

HilleVax is based in Boston, Massachusetts. HilleVax has raised $135M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in September 2021. The round record for HilleVax runs through 2021; nothing later has been disclosed. Investors on record include Frazier Life Sciences.

HilleVax at a glance

Total raised: $135M
Latest round: IPO
Latest round date: September 2021
Headquarters: Boston, Massachusetts
Notable investors: Frazier Life Sciences

Frequently asked about HilleVax funding

How much has HilleVax raised?: HilleVax has raised $135M in total disclosed funding across the rounds on record.
Who has invested in HilleVax?: Frazier Life Sciences are named among the investors backing HilleVax.
What was the latest HilleVax funding round?: The most recent disclosed round is an IPO, announced in September 2021.
Where is HilleVax based?: HilleVax is based in Boston, Massachusetts.
When did HilleVax last raise?: The last disclosed HilleVax round closed in September 2021 at IPO.

Totals shown for HilleVax aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.

HilleVax Funding: $135M Raised, IPO (2021)

HilleVax funding overview

HilleVax at a glance

Frequently asked about HilleVax funding

Companies related to HilleVax (36)

Browse related funding lists (6)